CME GROUP INC.

CME
Delayed Quote. Delayed  - 01/25 04:00:00 pm
184.37USD +0.18%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 4 8684 908
EBITDA1 3 2173 274
Operating profit (EBIT)1 3 0593 065
Operating Margin 62,8%62,5%
Pre-Tax Profit (EBT)1 2 6902 768
Net income1 2 1172 164
Net margin 43,5%44,1%
EPS2 5,916,03
Dividend per Share2 5,505,99
Last update 02/12/202001/15/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 2 1921 503
Net Cash position1 --
Leverage (Debt / EBITDA) 0,68x0,46x
Free Cash Flow1 2 4272 427
ROE (Net Profit / Equities) 9,35%8,92%
Shareholders' equity1 22 62524 273
ROA (Net Profit / Asset) 3,19%2,56%
Assets1 66 37584 540
Book Value Per Share2 72,975,1
Cash Flow per Share2 -7,28
Capex1 246170
Capex / Sales 5,05%3,46%
Last update 02/12/202001/13/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 66 187 M $ -
Entreprise Value (EV) 67 690 M $ 66 806 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 30,6x 30,1x
Capitalization / Revenue 13,5x 13,7x
EV / Revenue 13,8x 14,0x
EV / EBITDA 20,7x 21,0x
Yield (DPS / Price) 3,25% 3,30%
Price to book (Price / BVPS) 2,46x 2,44x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 62,5% 62,8%
Operating Leverage (Delta EBIT / Delta Sales) 0,28x -0,58x
Net Margin (Net Profit / Revenue) 44,1% 45,2%
ROA (Net Profit / Asset) 2,56% 2,12%
ROE (Net Profit / Equities) 8,92% 8,74%
Rate of Dividend 99,4% 99,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   3,46% 3,54%
Cash Flow / Sales 53,3% 57,8%
Capital Intensity (Assets / Sales) 17,2x 21,3x
Financial Leverage (Net Debt / EBITDA) 0,46x 0,19x
Price Earning Ratio
EPS & Dividend